Emilia Bulaevsky Zychlinsky
Direttore operativo presso Exai Bio, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Patrick Arensdorf | M | - |
Exai Bio, Inc.
 Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Elizabeth Ann Hutt Pollard | F | 57 | 9 anni | |
| Babak Alipanahi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Hani Goodarzi | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Mike Pellini | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Shaun Rodriguez | M | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | - |
| Seema Bhan | F | - |
Exai Bio, Inc.
Exai Bio, Inc. Packaged SoftwareTechnology Services Exai Bio, Inc. is an American next-generation liquid biopsy company founded by Hani Goodarzi, Babak Alipanahi, and Patrick Arensdorf. The company's mission is to enable early detection, accurate diagnosis, personalized and targeted treatment, and ultimately cure of cancer. Exai Bio's proprietary RNA- and AI-based liquid biopsy technology delivers clinical insights into cancer biology to enable the earliest and most accurate diagnosis of cancer. Patrick Arensdorf has been the CEO since incorporation. | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Brian E. Ward | M | 71 | 4 anni | |
| Patrick Plewman | M | 58 | 1 anni | |
| Lori F. Rafield | M | 69 | 8 anni | |
| Christopher Lowe | M | 56 | - | |
| Alexander Johnson | M | - | 1 anni | |
| Sarah Schiltz | F | - | 4 anni | |
| John Curnutte | M | 72 | 1 anni | |
| Leone Patterson | F | 61 | 1 anni | |
| Andrew Galligan | M | 67 | 5 anni | |
| James Sulat | M | 73 | 1 anni | |
| David J. Foster | M | 66 | 1 anni | |
| Louis C. Bock | M | 59 | 1 anni | |
| Charles W. Patrick | M | 69 | 5 anni | |
| Adeoye Olukotun | M | 79 | 2 anni | |
| Paul Manners | M | - | - | |
| Jonathan Ruais | M | 47 | 1 anni | |
| William Harrison Hammond | M | - | 1 anni | |
| Mika Newton | M | - | - | |
| Robert Michael Richey | M | 71 | 3 anni | |
| Jean-Frédéric Viret | M | 58 | 2 anni | |
| E. Ralf Schoenbrunner | M | - | - | |
| Kenneth Charles Fang | M | 61 | - | |
| John Sperzel | M | 60 | - | |
| Robert J. Schott | M | - | - | |
| David W. Nikka | M | 69 | 2 anni | |
| Robert L. Wolfert | M | 70 | 1 anni | |
| Alexander Johnson | M | 50 | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 34 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Emilia Bulaevsky Zychlinsky
- Contatti personali
